Better treatment, better health! People often experience suboptimal health because treatment is not optimal. A new approach is being developed - enabling patients and doctors to improve treatment and improve health.
Title. Does Giving the Doctor a Document Template with the Patient's Own Values and Preferences When Making Decisions about Starting Medication Improves Shared Decision Making?
Presented by BITO, Seiji
@ SMDM2019 postersession
Concise explaining of Evidence-Based Medicine and discussing the following: 1-What is Evidence-Based Medicine?
2-Why Evidence-based Medicine?
3-Options for changing clinicians' practice behaviour
4- EBM Process- Five Steps
5-Seven alternatives to evidence-based medicine
Evidence based practice (EBP) in physiotherapy Saurab Sharma
This presentation is the classroom lecture for undergraduate physiotherapy students whom I teach at Kathmandu University School of Medical Sciences in Nepal. This is an introductory lecture. Students carry on with steps of EBP in the years to come during the student life and use it for their presentations and clinical learning placement.
Other students too may benefit. I highly encourage other students, especially in some parts of India where EBP is not taught, and is reserved for Master's degree program. I completely disagree with this concept, as EBP is the pillar of a responsible physiotherapy practice. Early it starts, better it is.
Title. Does Giving the Doctor a Document Template with the Patient's Own Values and Preferences When Making Decisions about Starting Medication Improves Shared Decision Making?
Presented by BITO, Seiji
@ SMDM2019 postersession
Concise explaining of Evidence-Based Medicine and discussing the following: 1-What is Evidence-Based Medicine?
2-Why Evidence-based Medicine?
3-Options for changing clinicians' practice behaviour
4- EBM Process- Five Steps
5-Seven alternatives to evidence-based medicine
Evidence based practice (EBP) in physiotherapy Saurab Sharma
This presentation is the classroom lecture for undergraduate physiotherapy students whom I teach at Kathmandu University School of Medical Sciences in Nepal. This is an introductory lecture. Students carry on with steps of EBP in the years to come during the student life and use it for their presentations and clinical learning placement.
Other students too may benefit. I highly encourage other students, especially in some parts of India where EBP is not taught, and is reserved for Master's degree program. I completely disagree with this concept, as EBP is the pillar of a responsible physiotherapy practice. Early it starts, better it is.
Clinical Questions types .
A Hierarchy of Preprocessed Evidence.
EBM definition and value.
Knowledge and Skills Necessary for Optimal Evidence-Based Practice.
Basic computer and internet knowledge for electronic searching of the literature
Guidelines - what difference do they make? A Dutch perspectiveepicyclops
This lecture was given by Dr Raymond Ostelo of the EMGO Institute, VU University Medical Center, Amsterdam, to the North British Pain Association Spring Scientific Meeting in Edinburgh on Friday 18th May, 2007. His lecture forms part of a conference "Blurring the Boundaries - Managing Pain in Primary Care and Secondary Care".
An Introduction Patient Reported Outcome Measures (PROMS)Keith Meadows
An introduction to the key concepts of patient Reported Outcome Measures, including reliability and validity, generic versus disease specific,selection criteria and their adaptation for different cultural groups.
evidence based practice is best for the people working with patients
ebp should be used by the heath care provider.
ebp based upon clinical experties
best research evidence
patient preference and values
Evidence Based Practice is the integration of clinical expertise, patient values, and the best research evidence into the decision making process for patient care.
Clinical expertise refers to the clinician’s cumulated experience, education and clinical skills. The patient brings to the encounter his or her own personal preferences and unique concerns, expectations, and values.
The best research evidence is usually found in clinically relevant research that has been conducted using sound methodology.
Dr. Dee Mangin, Professor of Family Medicine and the Associate Chair and Director, Research, at McMaster University, will join practicing pharmacist, and Vice President, Pharmacy Affairs, Sandra Hanna of the Neighbourhood Pharmacy Association of Canada to discuss medication risks, deprescribing and the dangers of polypharmacy in this one hour webinar. Learn more at www.asklistentalk.ca
a brief overview about how and why to practice evidence based medicine, its clinical application, what it is and what it is not? benefits and challenges
Guide on the decision-making process regarding medical treatment in end-of-li...Council of Europe (CoE)
The purpose of this guide is to serve as a useful tool for informing the public and training professionals. It is aimed at health professionals, patients, their families and all those who face problematic decisions with regard to medical treatment in end-of-life situations, and provides help for the development of practices. The guide is also a source of material for any discussion held within our societies on the decision-making process regarding medical treatment in end-of-life situations in that it proposes benchmarks relating both to the practices and the principles that can be applied in this context.
Clinical Questions types .
A Hierarchy of Preprocessed Evidence.
EBM definition and value.
Knowledge and Skills Necessary for Optimal Evidence-Based Practice.
Basic computer and internet knowledge for electronic searching of the literature
Guidelines - what difference do they make? A Dutch perspectiveepicyclops
This lecture was given by Dr Raymond Ostelo of the EMGO Institute, VU University Medical Center, Amsterdam, to the North British Pain Association Spring Scientific Meeting in Edinburgh on Friday 18th May, 2007. His lecture forms part of a conference "Blurring the Boundaries - Managing Pain in Primary Care and Secondary Care".
An Introduction Patient Reported Outcome Measures (PROMS)Keith Meadows
An introduction to the key concepts of patient Reported Outcome Measures, including reliability and validity, generic versus disease specific,selection criteria and their adaptation for different cultural groups.
evidence based practice is best for the people working with patients
ebp should be used by the heath care provider.
ebp based upon clinical experties
best research evidence
patient preference and values
Evidence Based Practice is the integration of clinical expertise, patient values, and the best research evidence into the decision making process for patient care.
Clinical expertise refers to the clinician’s cumulated experience, education and clinical skills. The patient brings to the encounter his or her own personal preferences and unique concerns, expectations, and values.
The best research evidence is usually found in clinically relevant research that has been conducted using sound methodology.
Dr. Dee Mangin, Professor of Family Medicine and the Associate Chair and Director, Research, at McMaster University, will join practicing pharmacist, and Vice President, Pharmacy Affairs, Sandra Hanna of the Neighbourhood Pharmacy Association of Canada to discuss medication risks, deprescribing and the dangers of polypharmacy in this one hour webinar. Learn more at www.asklistentalk.ca
a brief overview about how and why to practice evidence based medicine, its clinical application, what it is and what it is not? benefits and challenges
Guide on the decision-making process regarding medical treatment in end-of-li...Council of Europe (CoE)
The purpose of this guide is to serve as a useful tool for informing the public and training professionals. It is aimed at health professionals, patients, their families and all those who face problematic decisions with regard to medical treatment in end-of-life situations, and provides help for the development of practices. The guide is also a source of material for any discussion held within our societies on the decision-making process regarding medical treatment in end-of-life situations in that it proposes benchmarks relating both to the practices and the principles that can be applied in this context.
ReadySetPresent (Decision Making PowerPoint Presentation Content): 100+ PowerPoint presentation content slides. Successful and effective strategic decision making is a guarantee to increase productivity in every workplace. Decision Making PowerPoint Presentation Content slides include topics such as: the 6 C’s of decision making, inherent personal and system traps, 10+ slides on decision trees, 10+ slides on decision making methods and tips, 4 slides on the GOR approach to decision making, 8 slides on common pitfalls in decision making, 4 slides on effective strategies in making decisions, 35+ slides on the 8 major decision making traps and how to effectively minimize each, 7 slides on different decision making perspectives, 25 slides on the 3 different types of analysis (grid analysis – paired comparison analysis, and cost/benefit analysis), 4 slides on utilizing planning and overarching questions, 4 modes of decision making and 6 factors in decision making and more!
When is it time for a new cancer treatment, and how should patients make these difficult decisions? Rachel Yung, MD, provides an overview of what to consider when making difficult treatment choices.
medication Adherence defined as the act of filling a new prescription for the first time.
The extent to which the patients take medications as prescribed by the prescriber.
1820201Chapter 2Conducting Health ResearchHe.docxaulasnilda
1/8/2020
1
Chapter 2
Conducting Health Research
Health Psychology (PSYC 172)
Professor: Andrea Cook, PhD
January 9, 2020
1
Placebos
• Placebo - inactive substance or condition that
has the appearance of an active treatment
• A belief in the effectiveness of a treatment
boosts the treatment’s effectiveness
• Placebo effect may account for around 35%
of treatment effects
• Placebos have been shown to lead to positive
health outcomes for many health disorders and
symptoms
– Migraine headaches, pain, depression,
anxiety, insomnia, asthma, hypertension
Research and the Placebo
• Treatments are effective when the treatment is more
effective than the placebo
• To determine if treatments are effective
– Need to directly compare treatment versus the
placebo
– Use two groups of people: one group receives
treatment and one group receives placebo
What you think about the treatment will impact its
effectiveness.
Who should you believe to decide if a treatment is likely to
be effective?
1/8/2020
2
Correlation Studies
Correlation is not causation
4
Correlation Studies
5
Correlation Studiies
6
http://www.tylervigen.com/spurious-correlations
1/8/2020
3
Correlation Studies
7
http://www.tylervigen.com/spurious-correlations
Correlation Studies
• Example – cholesterol
– Consumed cholesterol raises blood cholesterol
– Dietary guidelines recommend low cholesterol diet
for last 50+ years without validation
– Today causal relationship completely invalidated
• The French Paradox (1991)
– Serge Renaud, French researcher
– Disconnect French high saturated fat consumption
and low rates of cardiovascular disease
– Attributed to large red wine consumption
8
Longitudinal Studies
9
1/8/2020
4
Longitudinal Studies
• Longitudinal studies draw conclusions about how
individuals change over time
– Follow the same set of participants over time
– Example - if a researcher wanted to know how
dietary choices affect health across the lifespan
• Annual diet survey over 20 years and analyze
major medical diagnoses
• Challenges – self report accuracy, other lifestyle
factors
Determining Causality
• Correlational, cross-sectional, and
longitudinal designs only examine
relationships between variables
– They do not determine causality - if one
variable directly causes another variable
Experimental Design
• Experimental designs — compare at least two
groups to be able to draw cause and effect
conclusions
– The experimental group receives treatment
– The control group does not receive treatment
• Randomized Controlled Trial (RCT) — similar
to experimental studies
– Participants are randomly assigned to either a study
group or a control group
– RCTs are considered the “gold standard” of research
design
1/8/2020
5
The Hidden Side of Clinical Trials
13The hidden side of clinical trials | Sile Lane | TEDxMadrid (YouTube)
Research for Marketing Purposes
14
Research for M ...
20131210 Electronic Health Records - Is the NHS ready? What about patientsamirhannan
On 12th December 2013, Dr Hannan (GP / family physician) along with Marilyn Gollom (patient) presented this talk to Health 2.0 Manchester. You can watch the talk by going to http://www.htmc.co.uk/pages/pv.asp?p=htmc0519.
Self advocacy is about taking a proactive approach to all stages of health and illness: prevention, diagnosis, treatment, and recovery. When people take an active role in their care, research shows they fare better both in satisfaction and in how well treatments work. In this talk you will learn how to develop the skills to be a good self-advocate, communicate effectively with your doctors, evaluate the latest health news headlines and find the best health information online.
Ethics and Learning Health Care: an overview of the differences between what is considered research and what is considered clinical care, and an introduction to the ethical issues that arise from this boundary being blurred.
Evidence-Based Practice Guidelines and Shared Decision Making: Conflicting or...Zackary Berger
How can we bridge physician guidelines, based on the best available evidence, and patient preferences? This workshop was given at the Society of General Internal Medicine 2015 Annual Meeting in Toronto, Canada.
Session Coordinator: Zackary Berger, MD, PhD
Additional Faculty: Michael J. Barry, MD, Kathleen Fairfield, MD, Leigh H. Simmons, MD, James Yeh, MD, Daniella A. Zipkin, MD, Dave deBronkart
Public Perspectives on Personalized Medicine: A Survey of U.S. Public OpinionPMCoalition
A representative survey of 1,001 Americans released today by the Personalized Medicine Coalition (PMC) and GenomeWeb shows that most Americans are not familiar with personalized medicine, an evolving approach to medicine that can make the health system more efficient and effective.
Similar to Decide treatment - a new approach to better health (20)
En ny type verktøy gjør det mulig for pasient og lege sammen å velge og styre behanlingen ut fra hva som gir best effekt for enkeltpasienten, og ut fra hva som er viktig for ham eller henne.
Avdeling for kunnskapsstøtte er hele Sykehuset Innlandets avdeling og betjener alle 8000 ansatte ved sykehusene i Gjøvik, Lillehammer, Hamar, Reinsvoll, Tynset, Elverum, Kongsvinger og Sanderud. Vi bistår også alle DPSer, DMSer og andre mindre enheter. Avdelingen yter bibliotektjenester, og bistår i utvikling og implementering av kunnskapsbaserte behandlingslinjer, fagprosedyrer, behandlingsplaner og informasjon til pasienter. Vi arbeider for bedre pasientdokumentasjon og gir tilgang til et vidt spekter av kunnskapsressurser. Avdelingen har ansvaret for et prosjekt som skal samordne alle faglige prosedyrer i foretaket. Flere innovasjons- og forskningsprosjekter er knyttet til avdelingens virksomhet.
An MCDA-based patient decision aid for patients with bipolar disorderØystein Eiring
How can patients be enabled to participate in decisions concerning their health? How can decisions be improved, concordent with patient values? A new patient decision aid will capitalise on network meta-analysis and single subject research designs to foster better decisions.
Avdeling for kunnskapsstøtte i Sykehuset Innlandet HFØystein Eiring
Sykehuset Innlandet har gjennom flere år satset målrettet på kunnskapsbasert praksis, blant annet ved å opprette en egen Avdeling for kunnskapsstøtte. Presentasjonen beskriver status, utfordringer og muligheter for avdelingen i mars 2011, et halvt år etter at den ble opprettet.
How can a health trust foster evidence-baced practice? The presentation gives an overview on how a norwegian health trust, in a region with 400 000 inhabitants, systematically works to get new knowledge into practice.
Helsebiblioteket er offentlig finansiert og gir tilgang til en rekke kunnskapsressurser både for norsk helsepersonell, og for befolkningen i Norge generelt.
Nettets ånd er i økende grad å dele. Ingen som arbeider i helsesektoren i dag, er vokst opp med internett. Vi bringer derfor lett med oss begrensninger fra den gamle verden, som ikke lenger fins.
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
CHAPTER 1 SEMESTER V - ROLE OF PEADIATRIC NURSE.pdfSachin Sharma
Pediatric nurses play a vital role in the health and well-being of children. Their responsibilities are wide-ranging, and their objectives can be categorized into several key areas:
1. Direct Patient Care:
Objective: Provide comprehensive and compassionate care to infants, children, and adolescents in various healthcare settings (hospitals, clinics, etc.).
This includes tasks like:
Monitoring vital signs and physical condition.
Administering medications and treatments.
Performing procedures as directed by doctors.
Assisting with daily living activities (bathing, feeding).
Providing emotional support and pain management.
2. Health Promotion and Education:
Objective: Promote healthy behaviors and educate children, families, and communities about preventive healthcare.
This includes tasks like:
Administering vaccinations.
Providing education on nutrition, hygiene, and development.
Offering breastfeeding and childbirth support.
Counseling families on safety and injury prevention.
3. Collaboration and Advocacy:
Objective: Collaborate effectively with doctors, social workers, therapists, and other healthcare professionals to ensure coordinated care for children.
Objective: Advocate for the rights and best interests of their patients, especially when children cannot speak for themselves.
This includes tasks like:
Communicating effectively with healthcare teams.
Identifying and addressing potential risks to child welfare.
Educating families about their child's condition and treatment options.
4. Professional Development and Research:
Objective: Stay up-to-date on the latest advancements in pediatric healthcare through continuing education and research.
Objective: Contribute to improving the quality of care for children by participating in research initiatives.
This includes tasks like:
Attending workshops and conferences on pediatric nursing.
Participating in clinical trials related to child health.
Implementing evidence-based practices into their daily routines.
By fulfilling these objectives, pediatric nurses play a crucial role in ensuring the optimal health and well-being of children throughout all stages of their development.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
13. HEALTH OPTIMISATION
1. Finds the
best available
treatment
2. Takes
the optimal
dosage
3. Uses
the treatment
as agreed
4. Leads
a very healthy
lifestyle
5. Takes
part in
decisions
6. Receives
enough
support
14. An approach from the UK calling
for the use of technology
Figure 1. Summary of the four principles of medicines optimization
15. Increasing the effectiveness of adherence
interventions may have
a far greater impact
on the health of the population
than any improvement in specific
medical treatments
Bryan Haynes
16. Increasing the effectiveness of adherence
interventions may have
a far greater impact
on the health of the population
than any improvement in specific
medical treatments
Bryan Haynes
And this is
only problem
#3 of the 6
18. 1. Finds the
best available
treatment
2. Takes
the optimal
dosage
3. Uses
the treatment
as agreed
4. Leads
a very healthy
lifestyle
5. Takes
part in
decisions
6. Receives
enough
support
21. HVA ER BEST
Å GJØRE?TEKNISK STØTTE:
• Systematisk monitorering av effekter
• Monitorering av annen info, som søvn og labsvar
• Optimalisering av compliance
• Integrert kunnskap fra mange kilder
• Rangering av behandlinger ut fra forskning og reelle
effekter
• Hjelp til å formidle kunnskap til henne på en forståelig
måte
• Hjelp til å involvere henne i valget
Contributors:
25. Multi-criteria
decision analysis
Mathematics Behavioral decision theory
Economics Computer technology
Software engineering Information systems
• Includes exactly what is needed for
optimal decisions
• Enables valid and consistent
integration of large amounts of data
• Takes knowledge and preferences
as input for calculations of treatment
values for the individual
27. • What works for groups of people generally does not
work for you!
Time
DevelopmentVariable
• Measure treatment effects and find out:
Right: With treatment
Middle: Without treatment
Left: With treatment
• Conclusion: Less symptoms with treatment!
30. Shared decision-making1. Get the decision on the table
2. Acknowledge that it´s not possible to find the best treatment
without knowing what´s important to the patient
31. Shared decision-making1. Get the decision on the table
2. Acknowledge that it´s not possible to find the best treatment
without knowing what´s important to the patient
3. Get all available options on the table
32. Shared decision-making1. Get the decision on the table
2. Acknowledge that it´s not possible to find the best treatment
without knowing what´s important to the patient
3. Get all available options on the table
4. Ask what the patient wants the treatment to do for her
33. Shared decision-making1. Get the decision on the table
2. Acknowledge that it´s not possible to find the best treatment
without knowing what´s important to the patient
3. Get all available options on the table
4. Ask what the patient wants the treatment to do for her
5. Tell what the patient can expect from the best and worst
treatment, on all outcomes
34. Shared decision-making1. Get the decision on the table
2. Acknowledge that it´s not possible to find the best treatment
without knowing what´s important to the patient
3. Get all available options on the table
4. Ask what the patient wants the treatment to do for her
5. Tell what the patient can expect from the best and worst
treatment, on all outcomes
6. Find out which treatment fits her preferences most
35. Shared decision-making1. Get the decision on the table
2. Acknowledge that it´s not possible to find the best treatment
without knowing what´s important to the patient
3. Get all available options on the table
4. Ask what the patient wants the treatment to do for her
5. Tell what the patient can expect from the best and worst
treatment, on all outcomes
6. Find out which treatment fits her preferences most
7. Agree on what is the best treatment
36. Shared decision-making1. Get the decision on the table
2. Acknowledge that it´s not possible to find the best treatment
without knowing what´s important to the patient
3. Get all available options on the table
4. Ask what the patient wants the treatment to do for her
5. Tell what the patient can expect from the best and worst
treatment, on all outcomes
6. Find out which treatment fits her preferences most
7. Agree on what is the best treatment
8. Provide support and allow the patient to participate in the
decision process to the extent and in the ways preferred
38. Pilot:
Bipolar disorder
• A very complex disorder
• Highly invididual course and
treatment results
• Can be unpredictable
• Serious consequences
very common
• Fatal consequences not rare
53. Ranking and expected value
of available treatments
No action is evidence-
based in this world.
All human behaviour is
knowledge- and
preference-based
78. Where is shared
decision-making?
1. Finds the
best available
treatment
2. Takes
the optimal
dosage
3. Uses
the treatment
as agreed
4. Leads
a very healthy
lifestyle
5. Takes
part in
decisions
6. Receives
enough
support
here here
here
here
here
here
82. Systems in the
making for
people with:
• Heart disease
• Asthma
• Stroke
• Hypertension
• MS
• COPD
• Diabetes
• Bipolar disorder
• Palliative care
• Lung cancer
• Schizophrenia
• Pregnancy
• HIV
• Psoriasis/eczema
85. I don´t want to stop using this
Patients:
I feel safer having this system
I see the big picture very fast
Doctors:
We quickly get to the main issues
Results:
94. Take this
and come
back in
a month
We can continue
with business
as usual:
• No systematic measurement of
treatment effects
• Trust that our brains can process
all necessary data
• No digital support outside of the
encounter
96. Finding out what
works for you should
be as systematic as
finding out what works
for groups
(= research)
97. Optimisation of health
for each and every one of us
1. Finds the
best available
treatment
2. Takes
the optimal
dosage
3. Uses
the treatment
as agreed
4. Leads
a very healthy
lifestyle
5. Takes
part in
decisions
6. Receives
enough
support
Editor's Notes
Toril, as many of the others, would rightfully ask: What is the best treatment, the best medication, for me? This question could be part of quite different contexts. For instance.
Toril, as many of the others, would rightfully ask: What is the best treatment, the best medication, for me? This question could be part of quite different contexts. For instance.